MDSQF yields 458.61% · PFE yields 6.13%● Live data
📍 MDSQF pulled ahead of the other in Year 1
Combined, MDSQF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDSQF + PFE for your $10,000?
Minsud Resources Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Argentina. The company explores for copper, molybdenum, silver, and gold deposits. Its principal project is the Chita Valley project that consists of the Chita, Brechas Vacas, and Minas de Pinto mineral concessions, as well as five additional adjacent properties covering an area of approximately 19,883 hectares located in the province of San Juan, Argentina. The company also holds a 100% interest in La Rosita project, which consists of the Alfa II mine and Alfa III mining concessions covering an area of 5,986 hectares located in the low sulfidation epithermal metallogenic province of the Deseado Massif, Patagonia, Argentina. The company was formerly known as Rattlesnake Ventures Inc. and changed its name to Minsud Resources Corp. in May 2011. Minsud Resources Corp. was founded in 2003 and is headquartered in Toronto, Canada.
Full MDSQF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.